OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Latest Advances in Lung Adenocarcinoma

home / peer-exchange / nsclc9-advances
Lung Cancer Molecular Testing

EP. 1: Lung Cancer Molecular Testing

July 19th 2016
The Importance of Comprehensive Genomic Profiling

EP. 2: The Importance of Comprehensive Genomic Profiling

July 19th 2016
The Emergence of Liquid Biopsy in Lung Cancer

EP. 3: The Emergence of Liquid Biopsy in Lung Cancer

July 19th 2016
Molecular Testing in Squamous Cell Tumors

EP. 4: Molecular Testing in Squamous Cell Tumors

July 19th 2016
Refining Use of EGFR TKIs, Adding Bevacizumab

EP. 5: Refining Use of EGFR TKIs, Adding Bevacizumab

July 19th 2016
TKIs for EGFR Del19 and Beyond Progression

EP. 6: TKIs for EGFR Del19 and Beyond Progression

July 19th 2016

EP. 7: Osimertinib for the T790M Resistance Mutation

July 19th 2016

EP. 8: EGFR TKI Sequencing

July 19th 2016
ALK-Positive NSCLC

EP. 9: ALK-Positive NSCLC

July 19th 2016
Treatment Approaches in Non-Driver Adenocarcinoma

EP. 10: Treatment Approaches in Non-Driver Adenocarcinoma

July 19th 2016
Progression in Non-Driver Adenocarcinoma

EP. 11: Progression in Non-Driver Adenocarcinoma

July 19th 2016
Up-front Treatment Options for Squamous NSCLC

EP. 12: Up-front Treatment Options for Squamous NSCLC

July 19th 2016
The Role of Immunotherapy in Metastatic NSCLC

EP. 13: The Role of Immunotherapy in Metastatic NSCLC

July 19th 2016
Managing Toxicity in Immunotherapy for Lung Cancer

EP. 14: Managing Toxicity in Immunotherapy for Lung Cancer

July 19th 2016
Immunotherapy for Brain Metastases

EP. 15: Immunotherapy for Brain Metastases

July 19th 2016
PD-L1 Biomarker Testing

EP. 16: PD-L1 Biomarker Testing

July 19th 2016
Emerging Biomarkers for Lung Cancer

EP. 17: Emerging Biomarkers for Lung Cancer

July 19th 2016
What is on the Horizon for Immunotherapy in NSCLC?

EP. 18: What is on the Horizon for Immunotherapy in NSCLC?

July 19th 2016
Final Thoughts on NSCLC

EP. 19: Final Thoughts on NSCLC

July 19th 2016

Latest Conference Coverage

T-DM1 Plus Palbociclib Displays Activity in HER2+ Metastatic Breast Cancer

EL1SSAR Data Shed Light on Leveraging Atezolizumab Plus Nab-Paclitaxel in PD-L1+ TNBC

Pretreatment ctDNA Status Is Associated With Distant Recurrent-Free Survival in Early Breast Cancer

Zanidatamab/Chemotherapy Yields Responses and Is Safe in HER2-Expressing Metastatic Breast Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact